MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Movement disorders in Brain Sagging Syndrome- A Systematic Review

    A. Datta, A. Lenka (Minneapolis, USA)

    Objective: Objective: This study aims to systematically review the array of movement disorders observed in patients diagnosed with brain sagging syndrome (BSS) secondary to spontaneous…
  • 2024 International Congress

    Prospective Study of Gait and Multimodal MRI Biomarkers for Multiple System Atrophy

    F. Marchand, R. Viard, D. Devos, L. Defebvre, T. Ollivier, D. Guehl, G. Kuchcinski, C. Moreau (LILLE, France)

    Objective: We aimed to develop new multimodal biomarkers allowing objective monitoring of early MSA progression to improve outcome definition for future neuroprotective trials. Background: MSA…
  • 2024 International Congress

    Cholinergic denervation is more severe in patients with Parkinson disease compared to Progressive Supranuclear Palsy-Parkinsonism subtype: A [18F]-FEOBV PET study

    P. Kanel, G. Carli, J. Barr, T. Brown, S. Roytman, K. Frey, P. Scott, R. Koeppe, R. Albin, N. Bohnen (Ann Arbor, USA)

    Objective: : To investigate cholinergic brain regional differences between Progressive supranuclear palsy with parkinsonism (PSP-P) and Parkinson's disease (PD), using the highly selective radiotracer for…
  • 2024 International Congress

    Hydrocephalic Progressive Supranuclear Palsy: An Underrecognized Entity

    A. Premkumar, D. Lim, SK. Seetharaman, LF. Tan (Singapore, Singapore)

    Objective: We describe a case of NPH-like presentation of PSP, review literature surrounding this entity, and discuss key diagnostic considerations and implications. Background: Despite advances…
  • 2024 International Congress

    The links between frontal deficits and levels of inflammatory parameters in Progressive Supranuclear Palsy

    P. Alster, D. Otto-ślusarczyk, A. Drzewińska, K. Duszyńska-Wąs, A. Wiercińska-Drapało, M. Struga, N. Madetko-Alster (Warszawa, Poland)

    Objective: The goal of the research was to verify the possible association between the levels of inflammatory factors and frontal deficits in Progressive Supranuclear Palsy…
  • 2024 International Congress

    The Clinical Landscape of Progressive Supranuclear Palsy in an Underserved Community from Southwestern Colombia

    L. Ortega-Bolaños, G. Pinilla-Monsalve, V. Martinez-Villota (Cali, Colombia)

    Objective: To elucidate the clinical presentation of Progressive Supranuclear Palsy (PSP) in a cohort residing in underserved communities in Buenaventura, Colombia—the country's primary maritime port…
  • 2024 International Congress

    Clinical characteristics and Brain atrophy pattern in the prospective multicenter cohort of Progressive Supranuclear Palsy

    S. Lee, R. Kim, B. Jin, H. Kim, EJ. Yoon, YK. Kim, JH. Shin, HJ. Kim, JY. Lee (Seoul, Republic of Korea)

    Objective: This study aims to investigate volumetric brain MRI features, clinical parameters and their correlations in the Study of Comprehensive ANd multimodal marker-based Cohort of…
  • 2024 International Congress

    Nigral Neuroinflammation and Dopaminergic Neurons in PD, MSA and PSP: A Comparative Clinicopathological Study

    E. Backman, M. Gardberg, L. Luntamo, M. Peurla, T. Vahlberg, P. Borghammer, N. Stefanova, G. Wenning, V. Kaasinen (Turku, Finland)

    Objective: To investigate nigral neuroinflammatory markers and dopaminergic neuron counts in parkinsonian disorders, comparing their profiles across conditions. Background: In degenerative parkinsonian disorders, the primary…
  • 2024 International Congress

    Inclusion of PSP-Parkinsonism (PSP-P) phenotype in clinical trials – power calculation

    N. Olfati, S. Akhlaghi, A. Shoeibi, I. Litvan (San Diego, USA)

    Objective: PSP-P is the second most common PSP phenotype. To facilitate its inclusion in future clinical trials, we used longitudinal data from the TAUROS study…
  • 2024 International Congress

    Combined application of alpha-synuclein and 4-repeat tau seed amplification assays for the differential diagnosis of parkinsonian disorders

    E. Jabbari, E. Artikis, C. Orru`, D. Vaughan, N. Vijiaratnam, R. Fumi, M. Theilmann Jensen, M. Hodgson, T. Georgiades, L. Wu, D. Lux, R. Obrocki, B. Groveman, A. Hughson, O. Ansorge, K. Allinson, T. Warner, Z. Jaunmuktane, A. Misbahuddin, N. Leigh, B. Ghosh, K. Bhatia, A. Church, C. Kobylecki, M. Hu, J. Rowe, C. Blauwendraat, T. Foltynie, H. Morris, B. Caughey (London, United Kingdom)

    Objective: To assess alpha-synuclein (a-syn) and 4-repeat tau (4RT) seed amplification assay (SAA) positivity rates in biosamples from people with Parkinson’s disease (PD) and Progressive…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley